Literature DB >> 7288241

[Elevation of serum creatine phosphokinase during pindolol treatment (author's transl)].

K Imataka, A Seki, N Takahashi, J Fujii, Y Ohuchi, K Kuwako, T Umeda, K Machii, T Hasegawa, A Ozoe.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1981        PMID： 7288241

Source DB:  PubMed          Journal:  Nihon Naika Gakkai Zasshi        ISSN： 0021-5384


× No keyword cloud information.
  4 in total

1.  Double-blind comparison of urapidil and prazosin in the treatment of patients with essential hypertension.

Authors:  Y Kaneko
Journal:  Drugs       Date:  1988       Impact factor: 9.546

2.  Comparison of once daily atenolol, nitrendipine and their combination in mild to moderate essential hypertension.

Authors:  D Maclean; E T Mitchell; R Lewis; N Irvine; J S McLay; J McEwen; R R Coulson; N D Slater; T J Fitzsimons; D G McDevitt
Journal:  Br J Clin Pharmacol       Date:  1990-04       Impact factor: 4.335

3.  Selective beta-adrenoceptor partial agonist effects of pindolol and xamoterol on skeletal muscle assessed by plasma creatine kinase changes in healthy subjects.

Authors:  B Tomlinson; J M Cruickshank; Y Hayes; J C Renondin; J B Lui; B R Graham; A Jones; A D Lewis; B N Prichard
Journal:  Br J Clin Pharmacol       Date:  1990-11       Impact factor: 4.335

4.  Muscle cramps and elevated serum creatine phosphokinase levels induced by beta-adrenoceptor blockers.

Authors:  Y Imai; N Watanabe; J Hashimoto; A Nishiyama; H Sakuma; H Sekino; K Omata; K Abe
Journal:  Eur J Clin Pharmacol       Date:  1995       Impact factor: 2.953
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.